bf/NASDAQ:NVIV_icon.jpeg

NASDAQ:NVIV

InVivo Therapeutics Holdings Corp.

  • Stock

USD

Last Close

0.49

12/02 21:00

Market Cap

995.92K

Beta: 0.82

Volume Today

1.61M

Avg: 100.11K

PE Ratio

−0.09

PFCF: −0.08

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
net income
-38.76M
-
-18.35M
52.66%
-33.31M
81.59%
-23.44M
29.65%
-26.75M
14.11%
-23.42M
12.42%
-11.83M
49.49%
-9.07M
23.30%
-9.89M
9.05%
-10.49M
6.01%
depreciation and amortization
740.69K
-
752K
1.53%
689K
8.38%
553K
19.74%
395K
28.57%
91K
76.96%
322K
253.85%
329K
2.17%
372K
13.07%
445K
19.62%
deferred income tax
18.87M
-
376K
98.01%
-593K
-
2.31M
489.21%
-215K
-
-315K
46.51%
-159K
49.52%
stock based compensation
3.14M
-
3.21M
2.28%
4.67M
45.49%
5.06M
8.51%
4.11M
18.90%
618K
84.95%
268K
56.63%
215K
19.78%
315K
46.51%
159K
49.52%
change in working capital
145.84K
-
-1.45M
1,091.50%
625K
143.22%
1.37M
119.04%
65K
95.25%
-1.22M
1,972.31%
259K
121.28%
-1.00M
487.64%
354K
135.26%
-596K
268.36%
accounts receivables
inventory
accounts payables
-253.29K
-
-330K
30.29%
-48K
85.45%
489K
1,118.75%
-23K
104.70%
-173K
652.17%
127K
173.41%
-461K
462.99%
124K
126.90%
12K
90.32%
other working capital
399.13K
-
-1.12M
379.61%
673K
160.30%
880K
30.76%
88K
90%
-1.04M
1,286.36%
132K
112.64%
-543K
511.36%
230K
142.36%
-608K
364.35%
other non cash items
956.57K
-
173K
81.91%
11.01M
6,261.27%
306K
97.22%
188K
38.56%
11.62M
6,080.32%
667K
94.26%
215K
67.77%
315K
46.51%
159K
49.52%
net cash provided by operating activities
-14.91M
-
-15.28M
2.54%
-16.33M
6.84%
-16.74M
2.52%
-19.68M
17.58%
-12.31M
37.45%
-10.31M
16.23%
-9.53M
7.56%
-8.85M
7.13%
-10.48M
18.39%
investments in property plant and equipment
-748.46K
-
-47K
93.72%
-5K
89.36%
-107K
2,040.00%
-65K
39.25%
-65K
0%
-12K
81.54%
-41K
241.67%
-77K
87.80%
-160K
107.79%
acquisitions net
purchases of investments
-18.92M
-
-8.26M
56.35%
sales maturities of investments
12.52M
-
19.83M
58.47%
other investing activites
45K
-
net cash used for investing activites
-748.46K
-
-2K
99.73%
-5K
150%
-6.51M
130,060.00%
11.51M
276.89%
-65K
100.56%
-12K
81.54%
-41K
241.67%
-77K
87.80%
-160K
107.79%
debt repayment
-89.89K
-
-77K
14.34%
-268K
248.05%
-395K
47.39%
-423K
7.09%
-752K
77.78%
-100K
86.70%
common stock issued
16.41M
-
14.62M
10.91%
14.48M
0.94%
30.00M
107.15%
51K
99.83%
16.51M
32,274.51%
367K
97.78%
22.12M
5,926.98%
8.51M
61.53%
7.96M
6.43%
common stock repurchased
dividends paid
other financing activites
491.77K
-
224K
54.45%
8.86M
3,854.02%
191K
97.84%
-11K
105.76%
121K
1,200%
1K
99.17%
343K
34,200%
net cash used provided by financing activities
16.81M
-
14.77M
12.16%
23.07M
56.24%
29.79M
29.14%
-383K
101.29%
15.88M
4,246.21%
268K
98.31%
22.46M
8,281.34%
8.51M
62.12%
7.96M
6.43%
effect of forex changes on cash
net change in cash
1.16M
-
-521K
145.10%
6.74M
1,392.71%
6.54M
2.84%
-8.55M
230.72%
3.50M
140.95%
-10.06M
387.13%
12.89M
228.13%
-422K
103.27%
-2.68M
535.07%
cash at beginning of period
12.83M
-
13.98M
9.01%
13.46M
3.73%
14.92M
10.86%
21.46M
43.86%
13.27M
38.17%
16.77M
26.40%
6.72M
59.96%
19.60M
191.89%
19.18M
2.15%
cash at end of period
13.98M
-
13.46M
3.73%
20.19M
50.04%
21.46M
6.29%
12.91M
39.85%
16.77M
29.93%
6.72M
59.96%
19.60M
191.89%
19.18M
2.15%
16.50M
13.97%
operating cash flow
-14.91M
-
-15.28M
2.54%
-16.33M
6.84%
-16.74M
2.52%
-19.68M
17.58%
-12.31M
37.45%
-10.31M
16.23%
-9.53M
7.56%
-8.85M
7.13%
-10.48M
18.39%
capital expenditure
-748.46K
-
-47K
93.72%
-5K
89.36%
-107K
2,040.00%
-65K
39.25%
-65K
0%
-12K
81.54%
-41K
241.67%
-77K
87.80%
-160K
107.79%
free cash flow
-15.65M
-
-15.33M
2.07%
-16.33M
6.54%
-16.85M
3.14%
-19.75M
17.22%
-12.38M
37.33%
-10.33M
16.57%
-9.57M
7.27%
-8.93M
6.73%
-10.64M
19.16%

All numbers in USD (except ratios and percentages)